Granisetron to Prevent Vomiting After Cancer Chemotherapy
Granisetron, a serotonin (5-HT) antagonist similar to ondansetron, was recently approved by the US Food and Drug Administration for prevention of nausea and vomiting due to cancer chemotherapy. Although available in an oral formulation in other countries, granisetron is available here only for intravenous (IV) use....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Granisetron to Prevent Vomiting After Cancer Chemotherapy
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 926
Article Code: 926a
Date: July 8, 1994
Volume: 36
Pages: 61-62
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 926
Article Code: 926a
Date: July 8, 1994
Volume: 36
Pages: 61-62
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)